Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Miragaia RJ"'
Autor:
Pfeifer M; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK.; Leibniz-Institute of Virology (LIV) and University hospital Hamburg-Eppendorf (UKE), Hamburg, Germany., Brammeld JS; Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Price S; Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Pilling J; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Bhavsar D; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Farcas A; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Bateson J; Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Sundarrajan A; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Miragaia RJ; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Guan N; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Arnold S; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Tariq L; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Grondine M; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Talbot S; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Guerriero ML; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., O'Neill DJ; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Young J; Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK., Company C; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Dunn S; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Thorpe H; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Martin MJ; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Maratea K; Clinical Pharmacology & Safety, BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Barrell D; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Ahdesmaki M; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Mettetal JT; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., Brownell J; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK., McDermott U; Oncology R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0RE, UK. ultan.mcdermott@astrazeneca.com.
Publikováno v:
Communications biology [Commun Biol] 2024 Apr 24; Vol. 7 (1), pp. 497. Date of Electronic Publication: 2024 Apr 24.
Autor:
Lawson M; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Cureton N; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Ros S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Cheraghchi-Bashi A; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Urosevic J; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., D'Arcy S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Delpuech O; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., DuPont M; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Fisher DI; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Gangl ET; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Lewis H; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Trueman D; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Wali N; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Williamson SC; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Moss J; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Montaudon E; Institut Curie, Paris, France., Derrien H; Institut Curie, Paris, France., Marangoni E; Institut Curie, Paris, France., Miragaia RJ; Oncology Data Science, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Gagrica S; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Morentin-Gutierrez P; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Moss TA; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Maglennon G; Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Sutton D; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Polanski R; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Rosen A; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts., Cairns J; Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Zhang P; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Critchlow SE; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Scott JS; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Lindemann JPO; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Barry ST; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Klinowska T; Late Development, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Morrow CJ; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom., Carnevalli LS; The Discovery Centre, Biomedical Campus, AstraZeneca, Cambridge, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2023 Dec 01; Vol. 83 (23), pp. 3989-4004.
Autor:
Criscione SW; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA. Steven.Criscione@astrazeneca.com., Martin MJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Oien DB; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Gorthi A; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA.; Department of Cell Systems & Anatomy, Greehey Children's Cancer Research Institute, University of Texas at Health San Antonio, San Antonio, TX, USA., Miragaia RJ; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Zhang J; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Chen H; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Karl DL; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Mendler K; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Markovets A; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Gagrica S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Delpuech O; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Dry JR; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Grondine M; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Hattersley MM; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Urosevic J; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Floc'h N; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Drew L; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Yao Y; Research and Early Development, Oncology R&D, AstraZeneca, Boston, MA, USA. yiyao1147@gmail.com., Smith PD; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK. Paul.D.Smith@astrazeneca.com.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2022 Dec 27; Vol. 6 (1), pp. 95. Date of Electronic Publication: 2022 Dec 27.
Autor:
Pore N; AstraZeneca, Gaithersburg, Maryland., Wu S; AstraZeneca, Gaithersburg, Maryland., Standifer N; AstraZeneca, Gaithersburg, Maryland., Jure-Kunkel M; AstraZeneca, Gaithersburg, Maryland., de Los Reyes M; AstraZeneca, Gaithersburg, Maryland., Shrestha Y; AstraZeneca, Gaithersburg, Maryland., Halpin R; AstraZeneca, Gaithersburg, Maryland., Rothstein R; AstraZeneca, Gaithersburg, Maryland., Mulgrew K; AstraZeneca, Gaithersburg, Maryland., Blackmore S; AstraZeneca, Gaithersburg, Maryland., Martin P; AstraZeneca, Gaithersburg, Maryland., Meekin J 3rd; AstraZeneca, Gaithersburg, Maryland., Griffin M; AstraZeneca, Waltham, Massachusetts., Bisha I; AstraZeneca, Munich, Germany., Proia TA; AstraZeneca, Waltham, Massachusetts., Miragaia RJ; AstraZeneca, Cambridge, United Kingdom., Herbst R; AstraZeneca, Gaithersburg, Maryland., Gupta A; AstraZeneca, Gaithersburg, Maryland., Abdullah SE; AstraZeneca, Gaithersburg, Maryland., Raja R; AstraZeneca, Gaithersburg, Maryland., Frigault MM; AstraZeneca, Gaithersburg, Maryland., Barrett JC; AstraZeneca, Gaithersburg, Maryland., Dennis PA; AstraZeneca, Gaithersburg, Maryland., Ascierto ML; AstraZeneca, Gaithersburg, Maryland. ml.ascierto@gmailcom michael.oberst@astrazeneca.com., Oberst MD; AstraZeneca, Gaithersburg, Maryland. ml.ascierto@gmailcom michael.oberst@astrazeneca.com.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 Nov; Vol. 11 (11), pp. 2828-2845. Date of Electronic Publication: 2021 Jul 06.
Autor:
Kumar S; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Instituto Gulbenkian de Ciência, Oeiras, Portugal., Fonseca VR; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal., Ribeiro F; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Instituto Gulbenkian de Ciência, Oeiras, Portugal., Basto AP; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Instituto Gulbenkian de Ciência, Oeiras, Portugal., Água-Doce A; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Instituto Gulbenkian de Ciência, Oeiras, Portugal., Monteiro M; Instituto Gulbenkian de Ciência, Oeiras, Portugal., Elessa D; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal., Miragaia RJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Gomes T; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK., Piaggio E; Institut Curie, PSL Research University, INSERM U932, Paris F-75005, France.; Centre d'Investigation Clinique Biotherapie CICBT 1428, Institut Curie, Paris F-75005, France., Segura E; Institut Curie, PSL Research University, INSERM U932, Paris F-75005, France., Gama-Carvalho M; BioISI - Biosystems and Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisboa 1749-016, Portugal., Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.; Theory of Condensed Matter Group, Cavendish Laboratory/Department of Physics, University of Cambridge, JJ Thomson Ave., Cambridge CB3 0HE, UK., Graca L; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal. lgraca@medicina.ulisboa.pt.; Instituto Gulbenkian de Ciência, Oeiras, Portugal.
Publikováno v:
Science immunology [Sci Immunol] 2021 May 28; Vol. 6 (59).
Autor:
Madissoon E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.; European Molecular Biology Laboratory - European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK., Wilbrey-Clark A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Miragaia RJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Saeb-Parsy K; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, UK., Mahbubani KT; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, UK., Georgakopoulos N; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, UK., Harding P; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Polanski K; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Huang N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Nowicki-Osuch K; MRC Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge, CB2 0XZ, UK., Fitzgerald RC; MRC Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge, CB2 0XZ, UK., Loudon KW; Molecular Immunology Unit, Department of Medicine, Cambridge, CB2 0QQ, UK., Ferdinand JR; Molecular Immunology Unit, Department of Medicine, Cambridge, CB2 0QQ, UK., Clatworthy MR; Molecular Immunology Unit, Department of Medicine, Cambridge, CB2 0QQ, UK., Tsingene A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., van Dongen S; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Dabrowska M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Patel M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Stubbington MJT; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK.; 10x Genomics Inc., 6230 Stoneridge Mall Road, Pleasanton, CA, 94588, USA., Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK., Stegle O; European Molecular Biology Laboratory - European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK., Meyer KB; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, UK. km16@sanger.ac.uk.
Publikováno v:
Genome biology [Genome Biol] 2019 Dec 31; Vol. 21 (1), pp. 1. Date of Electronic Publication: 2019 Dec 31.
Autor:
Miragaia RJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK; Centre of Biological Engineering, University of Minho, Braga, Portugal., Gomes T; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Chomka A; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Translational Gastroenterology Unit, Experimental Medicine Division Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Jardine L; Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK., Riedel A; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Hegazy AN; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Translational Gastroenterology Unit, Experimental Medicine Division Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Whibley N; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Tucci A; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Chen X; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Lindeman I; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK; Centre for Immune Regulation and Department of Immunology, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway., Emerton G; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Krausgruber T; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Translational Gastroenterology Unit, Experimental Medicine Division Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Shields J; MRC Cancer Unit, University of Cambridge, Cambridge, UK., Haniffa M; Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK., Powrie F; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Translational Gastroenterology Unit, Experimental Medicine Division Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK; Theory of Condensed Matter, Cavendish Laboratory, Department of Physics, University of Cambridge, Cambridge, UK; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK. Electronic address: st9@sanger.ac.uk.
Publikováno v:
Immunity [Immunity] 2019 Feb 19; Vol. 50 (2), pp. 493-504.e7. Date of Electronic Publication: 2019 Feb 05.
Autor:
Vieira Braga FA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. fvb@sanger.ac.uk., Miragaia RJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. rjudicemiragaia@gmail.com.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2019; Vol. 1979, pp. 9-21.
Autor:
Chen X; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK., Miragaia RJ; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; MedImmune, Sir Aaron Klug Building, Granta Park, Cambridge, CB21 6GH, UK., Natarajan KN; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Functional Biology and Metabolism Unit, Biochemistry and Molecular Biology, SDU, 5230, Odense, Denmark., Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK. st9@sanger.ac.uk.; EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK. st9@sanger.ac.uk.; Theory of Condensed Matter, Cavendish Laboratory, 19 JJ Thomson Ave, Cambridge, CB3 0HE, UK. st9@sanger.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2018 Dec 17; Vol. 9 (1), pp. 5345. Date of Electronic Publication: 2018 Dec 17.
Autor:
Massaia A; British Heart Foundation Centre of Research Excellence and British Heart Foundation Centre for Regenerative Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Chaves P; British Heart Foundation Centre of Research Excellence and British Heart Foundation Centre for Regenerative Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Samari S; British Heart Foundation Centre of Research Excellence and British Heart Foundation Centre for Regenerative Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Miragaia RJ; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Meyer K; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Teichmann SA; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom., Noseda M; British Heart Foundation Centre of Research Excellence and British Heart Foundation Centre for Regenerative Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2018 Nov 21; Vol. 5, pp. 167. Date of Electronic Publication: 2018 Nov 21 (Print Publication: 2018).